Elsevier Updates Major Reference Work, Comprehensive

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
234
Elsevier Updates Major Reference Work, Comprehensive Biomaterials II

CAMBRIDGE, MA --(Marketwired - June 08, 2017) - Elsevier , the information analytics company specializing in science and health, today announced the second edition of Comprehensive Biomaterials II , edited by Paul Ducheyne, Kevin Healy, Dietmar E. Hutmacher, David W. Grainger and C. James Kirkpatrick. One of five new biomaterials titles, this major reference work reviews the current status of nearly all biomaterials in the field by analyzing their strengths and weaknesses, performance, and future prospects.

The updated work covers all significant emerging technologies in areas such as 3D printing of tissues, organs and scaffolds, cell encapsulation; multimodal delivery, cancer/vaccine - biomaterial applications, neural interface understanding, materials used for in situ imaging, and infection prevention and treatment. With 75 percent new or revised articles, its seven volumes provide biomedical scientists in industry, government, academia and research organizations with an accessible and thoroughly accurate perspective on the field.

Learn more about silk biomaterials in this excerpt from Volume 2, also available in Elsevier's Reference Module in Materials Science and Materials Engineering .

Dr. Ducheyne is Professor of Bioengineering at the University of Pennsylvania, Philadelphia, USA, and a member of the Institute for Medicine and Engineering (IME) and the Center for Engineering Cells and Regeneration (CECR). His research is focused in the investigation of mechanistic effects of materials on cellular functions, specifically cell attachment, proliferation, differentiation and extracellular matrix formation, especially with respect to biomaterials and tissue engineering.

Dr. Healy is the Jan Fandrianto Distinguished Professor in Engineering at the University of California at Berkeley in the Departments of Bioengineering and Materials Science and Engineering. His research interests include the design and synthesis of biomimetic materials that actively direct the fate of embryonic and adult stem cells, and facilitate regeneration of damaged tissues and organs.

Dr. Hutmacher is the Director of the Centre of Regenerative Medicine and Director of the Australian Research Council Centre in Additive Biomanufacturing at the Queensland University of Technology (QUT). He has expertise in biomaterials, biomedical engineering, and tissue engineering and regenerative medicine (TE&RM), and is also among the pioneers in the field of 3D printing in medicine.

Dr. Grainger is the George S. and Dolores Dore´ Eccles Presidential Endowed Chair in Pharmaceutics and Pharmaceutical Chemistry, and Chair and Professor of Bioengineering at the University of Utah, USA. His research focuses on improving implanted medical device performance, drug delivery of new therapeutic proteins, nucleic acids and live vaccines, nanomaterials interactions with human tissues, low-infection biomaterials, and innovating diagnostic devices based on DNA and protein biomarker capture.

Dr. Kirkpatrick is Senior Professor in the Cranio-Maxillofacial Surgery Clinic at the Goethe University of Frankfurt, and Visiting Professor of Biomaterials & Regenerative Medicine at the University of Gothenburg, Sweden. His principal research interests continue to be in the field of biomaterials in tissue engineering and regenerative medicine, with special focus on the development of human cell culture techniques, including novel 3D coculture methodology for biomaterials and the application of modern molecular pathology techniques to the study of biofunctionality of biomaterials, including nanomaterials.

The five new biomaterials titles are:

In order to meet content needs in biomaterials, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books, which will educate the next generation of biomaterials researchers and engineers, and provide critical foundational content for information professionals, are key examples of how Elsevier is enabling science to drive innovation.

Note for Editors Only credentialed media can request eBook review copies by email, sciencereviewcopies@elsevier.com

About Elsevier Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect , Scopus , ClinicalKey and Sherpath . Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell , more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy . Elsevier is part of RELX Group , a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

Image Available: http://www.marketwire.com/library/MwGo/2017/6...927491.jpg

Media Contact Pam Foote Publicity Contact, Science & Technology Books, Elsevier footep@reedelsevier.com +1-978-837-8182

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 94

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 126

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 104

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 100

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 191

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 161

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 41

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 111

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 161

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading

Top 5 Most Recently Viewed Articles

MSG Entertainment Reports Q1 Results for Fiscal 2025

Updated Category News Views 259

MSG Entertainment's Strong Start to Fiscal 2025 Madison Square Garden Entertainment Corp. (NYSE: MSGE) has released its financial results for the first quarter of fiscal 2025, providing insight into its performance and future expectations. The company, known for its impressive entertainment offerings, has experienced a robust period marked by several noteworthy...

Continue Reading
Asia Pacific Consumer Trends 2025: Emphasizing Intentional Spending

Updated Category News Views 1304

Embracing Intentional Spending in Asia Pacific NielsenIQ (NIQ), the foremost global consumer intelligence company, has published its Mid-Year Consumer Outlook (MYCO) report highlighting a significant transition among Asia Pacific consumers. This report underscores how consumers are moving away from cautious spending towards more intentional and purpose-driven consumption....

Continue Reading
BILL Holdings Sees Stock Surge as Investor Takes 8% Share

Updated Category News Views 303

Stock Rise for BILL Holdings Inc BILL Holdings Inc (NYSE: BILL) has experienced a noticeable surge in its stock price during after-hours trading recently. This uptick follows reports indicating that the activist investment firm Starboard Value has acquired an 8% stake in the company. Overview of the Recent Developments After hours, BILL stock showed signs of strength,...

Continue Reading
Saudi Fund for Development Fuels Growth in Serbia with $205M Deals

Updated Category News Views 84

Saudi Fund for Development Boosts Economic Growth in Serbia The Saudi Fund for Development (SFD) is making significant strides in fostering growth in Serbia through the signing of three major development loan agreements, totaling $205 million. This initiative marks the Fund's first venture into Serbia, reflecting its commitment to promoting sustainable development across...

Continue Reading
Chevron's 2025 Capex Budget and Strategic Update Overview

Updated Category News Views 487

Chevron's Strategic Vision for 2025 Capex Budget Chevron Corporation has announced its ambitious 2025 capital expenditure budget, setting the range between $14.5 to $15.5 billion for its consolidated subsidiaries, alongside an affiliate capex range of $1.7 to $2.0 billion. This capex approach emphasizes Chevron's commitment to operational excellence and enhanced...

Continue Reading